Harvest Fund Management Co., LTD Mirati Therapeutics, Inc. Transaction History

Harvest Fund Management Co., LTD

  • $1.66 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$158.92 - $221.61 $12,554 - $17,507
-79 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$162.05 - $240.27 $36,623 - $54,301
-226 Reduced 74.1%
79 $17,000
Q3 2020

Nov 04, 2020
BUY
$113.26 - $167.27 $34,544 - $51,017
305 New
305 $51,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email